Basit öğe kaydını göster

dc.contributor.authorUlus, Bahar
dc.contributor.authorCeliksoz, Muzeyyen
dc.contributor.authorOzhan, Gül
dc.date.accessioned2021-03-03T15:23:52Z
dc.date.available2021-03-03T15:23:52Z
dc.date.issued2017
dc.identifier.citationUlus B., Celiksoz M., Ozhan G., "Cytotoxicity and genotoxicity of fenoxaprop-p-ethyl and fluzifob-p-butyl herbicides", ISTANBUL JOURNAL OF PHARMACY, cilt.47, sa.1, ss.5-8, 2017
dc.identifier.otherav_3ec656b3-9c9e-4a9b-8b47-79cfc7be3e1e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/46041
dc.identifier.urihttps://doi.org/10.5152/istanbuljpharm.2017.002
dc.description.abstractHuman populations are exposed to several toxic substances in the environment, including pesticides. Fenoxaprop-p-ethyl (FPE) and fluzifob-p-butyl (FPB) herbicides are extensively used in agricultural fields due to their high target selectivity and low non-target toxicity. They are known as aryloxyphenoxypropionate herbicides, and acetyl-CoA carboxylase inhibitor. In the study, we aimed to evaluate the toxic potentials of FPE and FPB herbicides. Cell viability was evaluated by MTT assay in the range of 15.6-500.0 mu M exposure concentrations in mouse fibroblast (BALB/3T3) cell line. Also, we investigated their DNA damage potentials on BALB/3T3 cells by using alkaline Comet assay. The results indicated that FPE and FPB showed no evidence of DNA damage. And, the cell viability was more than 20% at 12.5-400 mu M exposure concentrations. FPE and FPB might be safe according to our results and the previously studies, and there would be public health benefits from encouraging its use in the place of more toxic herbicide products.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.titleCytotoxicity and genotoxicity of fenoxaprop-p-ethyl and fluzifob-p-butyl herbicides
dc.typeMakale
dc.relation.journalISTANBUL JOURNAL OF PHARMACY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume47
dc.identifier.issue1
dc.identifier.startpage5
dc.identifier.endpage8
dc.contributor.firstauthorID237921


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster